(Q39651374)

English

Combined activity of oridonin and wogonin in advanced-stage ovarian cancer cells: sensitivity of ovarian cancer cells to phyto-active chemicals

scientific article published on 26 September 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Combined activity of oridonin and wogonin in advanced-stage ovarian cancer cells: sensitivity of ovarian cancer cells to phyto-active chemicals (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

object named as

Sophie Chen

0 references

author name string

Matt Cooper

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Matt Jones

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Thumuluru Kavitha Madhuri

4

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Julie Wade

5

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Ashleigh Bachelor

6

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Simon Butler-Manuel

7

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

publication date

26 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Cell Biology and Toxicology

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

133-147

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

https://scigraph.springernature.com/pub.10.1007/s10565-010-9176-0

0 references

Akt promotes chemoresistance in human ovarian cancer cells by modulating cisplatin-induced, p53-dependent ubiquitination of FLICE-like inhibitory protein

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

Inflammation and cancer: back to Virchow?

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

An essential role for NF-kappaB in preventing TNF-alpha-induced cell death

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

The TOR pathway: a target for cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

Natural products as targeted modulators of the nuclear factor-kappaB pathway

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

Antiproliferative activity of sulforaphane in Akt-overexpressing ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

Effects of the flavonoid baicalin and its metabolite baicalein on androgen receptor expression, cell cycle progression and apoptosis of prostate cancer cell lines

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

Wogonoside inhibits lipopolysaccharide-induced angiogenesis in vitro and in vivo via toll-like receptor 4 signal transduction.

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

Double-edged swords as cancer therapeutics: simultaneously targeting p53 and NF-kappaB pathways.

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

Description of paclitaxel resistance-associated genes in ovarian and breast cancer cell lines

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

mTOR and cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

Wogonin sensitizes resistant malignant cells to TNFalpha- and TRAIL-induced apoptosis

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

Paclitaxel-resistant human ovarian cancer cells have mutant beta-tubulins that exhibit impaired paclitaxel-driven polymerization

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

Genistein-induced apoptosis and autophagocytosis in ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

Oridonin, a diterpenoid purified from Rabdosia rubescens, inhibits the proliferation of cells from lymphoid malignancies in association with blockade of the NF-kappa B signal pathways

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

Sulforaphane targets pancreatic tumour-initiating cells by NF-kappaB-induced antiapoptotic signalling

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

NF-kappaB: linking inflammation and immunity to cancer development and progression

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

Anti-inflammatory plant flavonoids and cellular action mechanisms

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

Reversal of Taxol resistance in hepatoma by cyclosporin A: involvement of the PI-3 kinase-AKT 1 pathway

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

Evi1 is a survival factor which conveys resistance to both TGFbeta- and taxol-mediated cell death via PI3K/AKT

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

PC-SPES: herbal formulation for prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

Targeting mammalian target of rapamycin synergistically enhances chemotherapy-induced cytotoxicity in breast cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

The emerging role of EpCAM in cancer and stem cell signaling

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

Mechanisms of Taxol resistance related to microtubules.

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

Ovarian cancer: emerging concept on cancer stem cells

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

PI3 K/Akt/mTOR-mediated translational control regulates proliferation and differentiation of lineage-restricted RoSH stem cell lines

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

Terpenoids: natural inhibitors of NF-kappaB signaling with anti-inflammatory and anticancer potential

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

Sensitization of ovarian cancer cells to cisplatin by genistein: the role of NF-kappaB.

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

Apoptotic effect of celecoxib dependent upon p53 status in human ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

Cancer chemoprevention with dietary phytochemicals

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

Role of TLR4 for paclitaxel chemotherapy in human epithelial ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPK

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

Activation of the PI3K/Akt pathway and chemotherapeutic resistance

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

Identification and characterization of ovarian cancer-initiating cells from primary human tumors

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

Survivin deregulation in beta-tubulin mutant ovarian cancer cells underlies their compromised mitotic response to taxol

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

Infertility, Fertility Drugs, and Ovarian Cancer: A Pooled Analysis of Case-Control Studies

1 reference

https://api.crossref.org/works/10.1007%2FS10565-010-9176-0

21 January 2018

Identifiers

10.1007/S10565-010-9176-0

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39651374&oldid=2101965510"